Yingchao L. Wang
The United Innovation Of Mengchao Hepatobiliary Technology Key Laboratory Of Fujian Province, 66 Jintang Road
Fuzhou, 350025, China
Fuzhou, 350025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
p53-R280S mutation confers lenvatinib resistance in hepatocellular carcinoma via Bcl-2-mediated anti-apoptotic signaling.
Journal: Molecular and cellular biochemistry
Published: February 13, 2026
Urinary Proteomics Enables Non-Invasive and Longitudinal Monitoring of Tumor Burden Dynamics and Early Recurrence in HCC.
Journal: Molecular & cellular proteomics : MCP
Published: December 23, 2025
T Cell Heterogeneity Shaped by Alternative Splicing Predicts Prognosis in Hepatocellular Carcinoma.
Journal: Cancer science
Published: December 18, 2025
Identification of intratumoral bacteria correlated with hepatitis B virus (HBV) levels: a prognostic indicator for patient outcomes in hepatocellular carcinoma patients.
Journal: Microbiology spectrum
Published: October 23, 2025
Comprehensive identification of microbial and metabolomic factors impacting ICC recurrence.
Journal: Frontiers in oncology
Published: September 11, 2025
Correction: Targeted Inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 25, 2025
Hypoxia-induced exosomal LUCAT1 promotes osimertinib resistance in lung adenocarcinoma by stabilizing c-MET.
Journal: Cell death & disease
Published: April 29, 2025
Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 26, 2025
Association of intratumoral microbiome diversity with hepatocellular carcinoma prognosis.
Journal: mSystems
Published: December 11, 2024
Reduced glutathione enhances adipose tissue-derived mesenchymal stem cell engraftment efficiency for liver fibrosis by targeting TGFβ1/SMAD3/NOX4 pathway.
Journal: Bioengineering & translational medicine
Published: June 11, 2024
Proteomic Analysis Identifies GSN as a Noninvasive Circulating Serum Biomarker for Predicting Early Recurrence of Hepatocellular Carcinoma.
Journal: Journal of proteome research
Published: February 19, 2024
Last Updated: 09/26/2026